Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England’s 100,000 Genomes Project to Advance Rare Disease Research

Dataset from more than 7,500 participants expands multiomic analysis in rare disease research by combining metabolomics with genomic and clinical data MORRISVILLE, N.C., June 24, 2026 — Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, today announced the successful completion and delivery of comprehensive metabolomic data generated through its collaboration with Genomics England, first publicized in October 2023. The dataset includes metabolomic profiles from more than 7,500 participants from the 10